NEW YORK(GenomeWeb) – OncoDNA and Progenetics today announced a distribution agreement for OncoDNA's products in Israel. 

Under the terms of the deal, OncoDNA will be Progenetics' preferred supplier of clinical-grade molecular theranostic products. OncoDNA will provide its OncoDeep DX and clinical cancer panels in combination with its Package Plus cancer-specific immunohistochemistry-based tests, and other tests for analyzing the presence, activity, and translocations of key proteins. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.